Don’t miss the latest developments in business and finance.

Glaxo in pact with Astellas, Japan

Image
BS Reporter Mumbai
Last Updated : Jan 20 2013 | 9:08 PM IST

Hasit Joshipura, managing director, GSK India, said, "One of our growth plans is to partner with global pharmaceutical companies for licensing in important molecules. The agreement with Astellas is in line with our strategy."

The company hopes that micafungin will strengthen its presence in intensive care and will provide an excellent fit with oncology where GSK has a promising R&D pipeline.

On the Bombay Stock Exchange, the GSK's stocks were trading at Rs 1,055, up 1.04 per cent at 1054 IST.

Also Read

First Published: May 14 2008 | 11:18 AM IST

Next Story